{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T20:02:45Z","timestamp":1769976165618,"version":"3.49.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,11,24]],"date-time":"2006-11-24T00:00:00Z","timestamp":1164326400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1038\/sj.eye.6702637","type":"journal-article","created":{"date-parts":[[2006,11,24]],"date-time":"2006-11-24T15:25:42Z","timestamp":1164381942000},"page":"354-362","source":"Crossref","is-referenced-by-count":16,"title":["Cost-effectiveness of early detection and treatment of ocular hypertension and primary open-angle glaucoma by the ophthalmologist"],"prefix":"10.1038","volume":"22","author":[{"given":"A","family":"Peeters","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J S A G","family":"Schouten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C A B","family":"Webers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M H","family":"Prins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Hendrikse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J L","family":"Severens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,11,24]]},"reference":[{"key":"BF6702637_CR1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/bjo.80.5.389","volume":"80","author":"HA Quigley","year":"1996","unstructured":"Quigley HA . Number of people with glaucoma worldwide. Br J Ophthalmol 1996; 80: 389\u2013393.","journal-title":"Br J Ophthalmol"},{"key":"BF6702637_CR2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/bmj.331.7517.E376","volume":"331","author":"R Harris","year":"2005","unstructured":"Harris R . Screening for glaucoma. BMJ 2005; 331: 376\u2013377.","journal-title":"BMJ"},{"key":"BF6702637_CR3","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","volume":"120","author":"MA Kass","year":"2002","unstructured":"Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002; 120: 701\u2013713.","journal-title":"Arch Ophthalmol"},{"key":"BF6702637_CR4","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","volume":"120","author":"A Heijl","year":"2002","unstructured":"Heijl A, Leske MC, Bengtsson B, Hyman L, Hussein M . Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002; 120: 1268\u20131279.","journal-title":"Arch Ophthalmol"},{"key":"BF6702637_CR5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0039-6257(83)90098-X","volume":"28","author":"LK Gottlieb","year":"1983","unstructured":"Gottlieb LK, Schwartz B, Pauker SG . Glaucoma screening. A cost-effectiveness analysis. Survey Ophthalmol 1983; 28: 206\u2013226.","journal-title":"Survey Ophthalmol"},{"key":"BF6702637_CR6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0008-4182(05)80010-9","volume":"40","author":"P Harasymowycz","year":"2005","unstructured":"Harasymowycz P, Kamdeu Fansi A, Papamatheakis D . Screening for primary open-angle glaucoma in the developed world: are we there yet? Canad J Ophthalmol 2005; 40: 477\u2013486.","journal-title":"Canad J Ophthalmol"},{"key":"BF6702637_CR7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1370\/afm.293","volume":"3","author":"C Fleming","year":"2005","unstructured":"Fleming C, Whitlock EP, Beil T, Smit B, Harris RP . Screening for primary open-angle glaucoma in the primary care setting: an update for the US preventive services task force. Annal Family Med 2005; 3: 167\u2013170.","journal-title":"Annal Family Med"},{"key":"BF6702637_CR8","doi-asserted-by":"crossref","unstructured":"US preventive services task forces. Screening for glaucoma: recommendation statement. Annals Family Med 2005; 3: 171\u2013172.","DOI":"10.1370\/afm.294"},{"key":"BF6702637_CR9","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1001\/archopht.116.12.1640","volume":"116","author":"RC Wolfs","year":"1998","unstructured":"Wolfs RC, Klaver CC, Ramrattan RS, van Duijn CM, Hofman A, de Jong PT . Genetic risk of primary open-angle glaucoma. Population-based familial aggregation study. Arch Ophthalmol 1998; 116: 1640\u20131645.","journal-title":"Arch Ophthalmol"},{"key":"BF6702637_CR10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archopht.1994.01090130079022","volume":"112","author":"JM Tielsch","year":"1994","unstructured":"Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC . Family history and risk of primary open angle glaucoma. The Baltimore Eye Survey. Arch Ophthalmol 1994; 112: 69\u201373.","journal-title":"Arch Ophthalmol"},{"key":"BF6702637_CR11","unstructured":"American Academy of Ophthalmology. Preferred Practice Patterns: Primary Open-Angle Glaucoma. American Academy of Ophthalmology: San Francisco, CA, 2000."},{"key":"BF6702637_CR12","volume-title":"Transmuraal Model Oogzorg (Transmural Model Eyecare)","author":"FG Van der Horst","year":"2003","unstructured":"Van der Horst FG, Webers CAB, Bours SJM . Transmuraal Model Oogzorg (Transmural Model Eyecare). Datawyse: Maastricht, 2003."},{"key":"BF6702637_CR13","first-page":"1","volume":"162","author":"H Koch","year":"1989","unstructured":"Koch H . Practice Patterns of the Office-Based Ophthalmologist, National Ambulatory Medical Care Survey, 1985. Adv Data 1989; 162: 1\u201312.","journal-title":"Adv Data"},{"key":"BF6702637_CR14","first-page":"1","volume":"262","author":"SM Schappert","year":"1995","unstructured":"Schappert SM . Office visits for glaucoma: United States, 1991\u201392. Advance data 1995; 262: 1\u201314.","journal-title":"Advance data"},{"key":"BF6702637_CR15","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1001\/archopht.120.6.804","volume":"120","author":"LB Ellwein","year":"2002","unstructured":"Ellwein LB, Urato CJ . Use of eye care and associated charges among the Medicare population: 1991\u20131998. Arch Ophthalmol 2002; 120: 804\u2013811.","journal-title":"Arch Ophthalmol"},{"key":"BF6702637_CR16","unstructured":"European Glaucoma Society. Terminology and Guidelines for Glaucoma. Editrice Dogma\u00ae S.r.I.: Savona\u2013Italy, 2003."},{"key":"BF6702637_CR17","unstructured":"Centraal Bureau voor de Statistiek (CBS). Statline. Available at: http:\/\/statline.cbs.nl . Accessed 8 September 2003."},{"key":"BF6702637_CR18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1755-3768.1984.tb08395.x","volume":"62","author":"JE Jensen","year":"1984","unstructured":"Jensen JE . Glaucoma screening: a 16-year follow-up of ocular normotensives. Acta Ophthalmol 1984; 62: 203\u2013209.","journal-title":"Acta Ophthalmol"},{"key":"BF6702637_CR19","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/bjo.57.3.186","volume":"57","author":"SE Perkins","year":"1973","unstructured":"Perkins SE . Bedford Glaucoma Survey II. Rescreening of the normal population. Br J Ophthalmol 1973; 57: 186\u2013192.","journal-title":"Br J Ophthalmol"},{"key":"BF6702637_CR20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1755-3768.1981.tb02996.x","volume":"59","author":"B Bengtsson","year":"1981","unstructured":"Bengtsson B . Manifest glaucoma in the aged I: occurrence nine years after a population survey. Acta Ophthalmol 1981; 59: 321\u2013331.","journal-title":"Acta Ophthalmol"},{"key":"BF6702637_CR21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1755-3768.1978.tb05689.x","volume":"56","author":"PN Sorensen","year":"1978","unstructured":"Sorensen PN, Nielsen NV, Norskov K . Ocular hypertension. A 15-year follow-up. Acta Ophthalmol 1978; 56: 363\u2013372.","journal-title":"Acta Ophthalmol"},{"key":"BF6702637_CR22","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1755-3768.1987.tb07067.x","volume":"65","author":"L Lundberg","year":"1987","unstructured":"Lundberg L, Wettrell K, Linner E . Ocular hypertension. A prospective twenty-year follow-up study. Acta Ophthalmol 1987; 65: 705\u2013708.","journal-title":"Acta Ophthalmol"},{"key":"BF6702637_CR23","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0161-6420(89)32688-1","volume":"96","author":"DL Epstein","year":"1989","unstructured":"Epstein DL, Krug Jr JH, Hertzmark E, Remis LL, Edelstein DJ . A long-term clinical trial of timolol therapy versus no treatment in the management of glaucoma suspects. Ophthalmology 1989; 96: 1460\u20131467.","journal-title":"Ophthalmology"},{"key":"BF6702637_CR24","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s00417-002-0614-4","volume":"241","author":"D Kamal","year":"2003","unstructured":"Kamal D, Garway-Heath D, Ruben S, O'Sullivan F, Bunce C, Viswanathan A et al. Results of the betaxolol versus placebo treatment trial in ocular hypertension. Graefe's archive for clinical and experimental ophthalmology 2003; 241: 196\u2013203.","journal-title":"Graefe's archive for clinical and experimental ophthalmology"},{"key":"BF6702637_CR25","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1755-3768.1989.tb04110.x","volume":"67","author":"RJ Uusitalo","year":"1989","unstructured":"Uusitalo RJ, Palkama A . Long-term evaluation of timolol. Acta Ophthalmol 1989; 67: 573\u2013581.","journal-title":"Acta Ophthalmol"},{"key":"BF6702637_CR26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/BF02173443","volume":"219","author":"PJ Airaksinen","year":"1982","unstructured":"Airaksinen PJ, Valle O, Takki KK, Klemetti A . Timolol treatment of chronic open-angle glaucoma and ocular hypertension. A 2.5-year multicenter study. Graefe's Arch Clin Exp Ophthalmol 1982; 219: 68\u201371.","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"key":"BF6702637_CR27","first-page":"78","volume":"103","author":"GM Maclure","year":"1983","unstructured":"Maclure GM . Chronic open angle glaucoma treated with Timolol. A four year study. Trans Ophthalmol Soc UK 1983; 103: 78\u201383.","journal-title":"Trans Ophthalmol Soc UK"},{"key":"BF6702637_CR28","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s004170000189","volume":"238","author":"A Heijl","year":"2000","unstructured":"Heijl A, Bengtsson B . Long-term effects of timolol therapy in ocular hypertension: a double-masked, randomised trial. Graefe's Arch Clin Exp Ophthalmol 2000; 238: 877\u2013883.","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"key":"BF6702637_CR29","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0161-6420(87)33253-1","volume":"94","author":"BJ Shingleton","year":"1987","unstructured":"Shingleton BJ, Richter CU, Bellows AR, Hutchinson BT, Glynn RJ . Long-term efficacy of argon laser trabeculoplasty. Ophthalmology 1987; 94: 1513\u20131518.","journal-title":"Ophthalmology"},{"key":"BF6702637_CR30","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/archopht.1989.01070010866031","volume":"107","author":"U Ticho","year":"1989","unstructured":"Ticho U, Nesher R . Laser trabeculoplasty in glaucoma. Ten-year evaluation. Arch Ophthalmol 1989; 107: 844\u2013846.","journal-title":"Arch Ophthalmol"},{"key":"BF6702637_CR31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1055\/s-2008-1050214","volume":"193","author":"M Vogel","year":"1988","unstructured":"Vogel M, Ecker S, Cieplik G, Bernhardt G . Laser trabeculoplasty in glaucoma chronicum simplex. Results of a prospective, clinical study [in German]. Klinische Monatsblatter fur Augenheilkunde 1988; 193: 8\u201315.","journal-title":"Klinische Monatsblatter fur Augenheilkunde"},{"key":"BF6702637_CR32","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF00937283","volume":"235","author":"C Ustundag","year":"1997","unstructured":"Ustundag C, Diestelhorst M . Efficacy of argon laser trabeculoplasty: 3-year preliminary results of a prospective placebo-controlled study. Graefe's Arch Clin Exp Ophthalmol 1997; 235: 354\u2013358.","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"key":"BF6702637_CR33","first-page":"156","volume":"1","author":"D Spiegel","year":"1992","unstructured":"Spiegel D, Wegscheider E, Lund OE . Argon laser trabeculoplasty: long-term follow-up of at least 5 years. German J Ophthalmol 1992; 1: 156\u2013158.","journal-title":"German J Ophthalmol"},{"key":"BF6702637_CR34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0002-9394(01)00923-0","volume":"132","author":"CE Parc","year":"2001","unstructured":"Parc CE, Johnson DH, Oliver JE, Hattenhauer MG, Hodge DO . The long-term outcome of glaucoma filtration surgery. Am J Ophthalmol 2001; 132: 27\u201335.","journal-title":"Am J Ophthalmol"},{"key":"BF6702637_CR35","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/S0161-6420(99)90351-2","volume":"106","author":"AC Molteno","year":"1999","unstructured":"Molteno AC, Bosma NJ, Kittelson JM . Otago glaucoma surgery outcome study: long-term results of trabeculectomy\u20141976 to 1995. Ophthalmology 1999; 106: 1742\u20131750.","journal-title":"Ophthalmology"},{"key":"BF6702637_CR36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0161-6420(86)33771-0","volume":"93","author":"KA Lamping","year":"1986","unstructured":"Lamping KA, Bellows AR, Hutchinson BT, Afran SI . Long-term evaluation of initial filtration surgery. Ophthalmology 1986; 93: 91\u2013101.","journal-title":"Ophthalmology"},{"key":"BF6702637_CR37","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1755-3768.1991.tb04819.x","volume":"69","author":"V Popovic","year":"1991","unstructured":"Popovic V, Sjostrand J . Long-term outcome following trabeculectomy: II Visual field survival. Acta Ophthalmol 1991; 69: 305\u2013309.","journal-title":"Acta Ophthalmol"},{"key":"BF6702637_CR38","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195108248.001.0001","volume-title":"Cost-effectiveness in Health and Medicine","author":"MR Gold","year":"1996","unstructured":"Gold MR, Siegel JE, Russel LB et al. Cost-effectiveness in Health and Medicine. First press release. Oxford University Press: New York, 1996."},{"key":"BF6702637_CR39","unstructured":"Voorlichting aan glaucoompatienten (Education for glaucoma patients). Rapport, 2002; nr 143. College voor zorgverzekeringen: Amstelveen, the Netherlands, 2002."},{"key":"BF6702637_CR40","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0161-6420(02)01974-7","volume":"110","author":"PP Chen","year":"2003","unstructured":"Chen PP . Blindness in patients with treated open-angle glaucoma. Ophthalmology 2003; 110: 726\u2013733.","journal-title":"Ophthalmology"},{"key":"BF6702637_CR41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0002-9394(01)00912-6","volume":"132","author":"YH Kwon","year":"2001","unstructured":"Kwon YH, Kim CS, Zimmerman MB, Alward WL, Hayreh SS . Rate of visual field loss and long-term visual outcome in primary open-angle glaucoma. Am J Ophthalmol 2001; 132: 47\u201356.","journal-title":"Am J Ophthalmol"},{"key":"BF6702637_CR42","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/00061198-200106000-00007","volume":"10","author":"JB Oostenbrink","year":"2001","unstructured":"Oostenbrink JB, Rutten van Molken MP, Sluyter Opdenoordt TS . Resource use and costs of patients with glaucoma or ocular hypertension: a one-year study based on retrospective chart review in the Netherlands. J Glaucoma 2001; 10: 184\u2013191.","journal-title":"J Glaucoma"},{"key":"BF6702637_CR43","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s004170050165","volume":"236","author":"G Kobelt","year":"1998","unstructured":"Kobelt G, Jonsson L, Gerdtham U, Krieglstein GK . Direct costs of glaucoma management following initiation of medical therapy. A simulation model based on an observational study of glaucoma treatment in Germany. Graefe's Arch Clin Exp Ophthalmol 1998; 236: 811\u2013821.","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"key":"BF6702637_CR44","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1017\/S0266462399015299","volume":"15","author":"G Kobelt","year":"1999","unstructured":"Kobelt G, Jonsson L . Modeling cost of treatment with new topical treatments for glaucoma. Results from France and the United Kingdom. Int J Technol Assess Health Care 1999; 15: 207\u2013219.","journal-title":"Int J Technol Assess Health Care"},{"key":"BF6702637_CR45","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1136\/bjo.2005.067355","volume":"89","author":"CE Traverso","year":"2005","unstructured":"Traverso CE, Walt JG, Kelly SP et al. Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe. Br J Ophthalmol 2005; 89: 1245\u20131249.","journal-title":"Br J Ophthalmol"},{"key":"BF6702637_CR46","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1600-0420.2005.00560.x","volume":"84","author":"B Lindblom","year":"2006","unstructured":"Lindblom B, Nordmann JP, Sellem E et al. A multicentre, retrospective study of resource utilization and costs associated with glaucoma management in France and Sweden. Acta ophthalmol Scand 2006; 84: 74\u201383.","journal-title":"Acta ophthalmol Scand"},{"key":"BF6702637_CR47","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/00061198-200312000-00002","volume":"12","author":"M Iskedjian","year":"2003","unstructured":"Iskedjian M, Walker J, Vicente C, Trope GE, Buys Y, Einarson TR et al. Cost of glaucoma in Canada: analyses based on visual field and physician's assessment. J Glaucoma 2003; 12: 456\u2013462.","journal-title":"J Glaucoma"},{"key":"BF6702637_CR48","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1001\/archopht.124.1.12","volume":"124","author":"PP Lee","year":"2006","unstructured":"Lee PP, Walt JG, Doyle JJ, Kotak SV, Evans SJ, Budenz DL et al. A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma. Arch Ophthalmol 2006; 124: 12\u201319.","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"BF6702637_CR49","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1136\/bjo.87.10.1201","volume":"87","author":"C Meads","year":"2003","unstructured":"Meads C, Hyde C . What is the cost of blindness? Br J Ophthalmol 2003; 87 (10): 1201\u20131204.","journal-title":"Br J Ophthalmol"},{"key":"BF6702637_CR50","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/S0161-6420(01)00799-0","volume":"108","author":"LM Weih","year":"2001","unstructured":"Weih LM, Nanjan M, McCarty CA, Taylor HR . Prevalence and predictors of open-angle glaucoma: results from the visual impairment project. Ophthalmology 2001; 108: 1966\u20131972.","journal-title":"Ophthalmology"},{"key":"BF6702637_CR51","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/00061198-200212000-00015","volume":"11","author":"G Kobelt","year":"2002","unstructured":"Kobelt G . Health economics, economic evaluation, and glaucoma. J Glaucoma 2002; 11: 531\u2013539.","journal-title":"J Glaucoma"},{"key":"BF6702637_CR52","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0161-6420(03)00254-9","volume":"110","author":"MM Brown","year":"2003","unstructured":"Brown MM, Brown GC, Sharma S, Busbee B . Quality of life associated with visual loss: a time tradeoff utility analysis comparison with medical health states. Ophthalmology 2003; 110: 1076\u20131081.","journal-title":"Ophthalmology"},{"key":"BF6702637_CR53","volume-title":"Decision Making in Health and Medicine: Integrating Evidence and Values","author":"MGM Hunink","year":"2001","unstructured":"Hunink MGM, Glasziou PP, Siegel JE, Weeks JC, Pliskin JS, Elstein AS et al. Decision Making in Health and Medicine: Integrating Evidence and Values. Cambridge University Press: Cambridge, 2001."},{"key":"BF6702637_CR54","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00176782","volume":"232","author":"I Dielemans","year":"1994","unstructured":"Dielemans I, Vingerling JR, Hofman A, Grobbee DE, de Jong PT . Reliability of intraocular pressure measurement with the Goldmann applanation tonometer in epidemiological studies. Graefe's Arch Clin Exp Ophthalmol 1994; 232: 141\u2013144.","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"key":"BF6702637_CR55","first-page":"857","volume":"61","author":"B Grolman","year":"1990","unstructured":"Grolman B, Myers KJ, Lalle P . How reliable is the Goldmann tonometer as a standard? J Am Optometr Assoc 1990; 61: 857\u2013862.","journal-title":"J Am Optometr Assoc"},{"key":"BF6702637_CR56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0039-6257(93)90053-A","volume":"38","author":"MM Whitacre","year":"1993","unstructured":"Whitacre MM, Stein R . Sources of error with use of Goldmann-type tonometers. Survey Ophthalmol 1993; 38: 1\u201330.","journal-title":"Survey Ophthalmol"},{"key":"BF6702637_CR57","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/oxfordjournals.aje.a116013","volume":"134","author":"JM Tielsch","year":"1991","unstructured":"Tielsch JM, Katz J, Singh K et al. A population-based evaluation of glaucoma screening: the Baltimore Eye Survey. Am J Epidemiol 1991; 134: 1102\u20131110.","journal-title":"Am J Epidemiol"},{"key":"BF6702637_CR58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/09286589709058056","volume":"4","author":"MW Tuck","year":"1997","unstructured":"Tuck MW, Crick RP . The cost-effectiveness of various modes of screening for primary open angle glaucoma. Ophthalmic Epidemiology 1997; 4: 3\u201317.","journal-title":"Ophthalmic Epidemiology"},{"key":"BF6702637_CR59","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1056\/NEJM199304153281507","volume":"328","author":"HA Quigley","year":"1993","unstructured":"Quigley HA . Open-angle glaucoma. N Engl J Med 1993; 328: 1097\u20131106.","journal-title":"N Engl J Med"},{"key":"BF6702637_CR60","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s004170000209","volume":"238","author":"R Harper","year":"2000","unstructured":"Harper R, Reeves B . The sensitivity and specificity of direct ophthalmoscopic optic disc assessment in screening for glaucoma: a multivariate analysis. Graefe's Arch Clin Exp Ophthalmol 2000; 238: 949\u2013955.","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"key":"BF6702637_CR61","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0161-6420(00)00649-7","volume":"108","author":"RQ Ivers","year":"2001","unstructured":"Ivers RQ, Macaskill P, Cumming RG, Mitchell P . Sensitivity and specificity of tests to detect eye disease in an older population. Ophthalmology 2001; 108: 968\u2013975.","journal-title":"Ophthalmology"},{"key":"BF6702637_CR62","volume-title":"De gezondheidstoestand van de bevolking in Nederland: een actualisering","author":"IAM Mass","year":"1997","unstructured":"Mass IAM, Gijsen R, Lobbezoo IE, Poos MJJC . De gezondheidstoestand van de bevolking in Nederland: een actualisering, RIVM, Bilthoven (The health condition of the dutch population). Elsevier\/De Tijdstroom: Maarssen, the Netherlands, 1997."},{"key":"BF6702637_CR63","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0161-6420(99)90516-X","volume":"106","author":"HA Quigley","year":"1999","unstructured":"Quigley HA . Proportion of those with open-angle glaucoma who become blind. Ophthalmology 1999; 106: 2039\u20132041.","journal-title":"Ophthalmology"},{"key":"BF6702637_CR64","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/bjo.77.3.176","volume":"77","author":"JL Jay","year":"1993","unstructured":"Jay JL, Murdoch JR . The rate of visual field loss in untreated primary open angle glaucoma. Br J Ophthalmol 1993; 77: 176\u2013178.","journal-title":"Br J Ophthalmol"},{"key":"BF6702637_CR65","unstructured":"Commissie Farmaceutische hulp (CFH) van het College voor zorgverzekeringen (Health Care Insurance Board). Farmacotherapeutisch Kompas (Pharmacotherapeutic Compass) 2004; ISBN 90-70918-35-8."}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6702637.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6702637","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6702637.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T14:15:01Z","timestamp":1707401701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6702637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,24]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["BF6702637"],"URL":"https:\/\/doi.org\/10.1038\/sj.eye.6702637","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,24]]}}}